Trastuzumab-deruxtecan monotherapy in HER2-activated advanced non-small cell lung cancer pre-treated with platinum-based chemotherapy with or without immunotherapy
Bull Cancer. 2024 Mar 28:S0007-4551(24)00080-8. doi: 10.1016/j.bulcan.2024.01.011. Online ahead of print.NO ABSTRACTPMID:38553285 | DOI:10.1016/j.bulcan.2024.01.011 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 29, 2024 Category: Cancer & Oncology Authors: Charl ène Rivier Pernelle Lavaud Source Type: research
Issues and implementation of postoperative radiotherapy after flap reconstructive surgery in head and neck cancers
Bull Cancer. 2024 Mar 28:S0007-4551(24)00082-1. doi: 10.1016/j.bulcan.2024.02.002. Online ahead of print.ABSTRACTThe management of head and neck cancers is multidisciplinary, often relying on the use of combined treatments to maximize the chances of cure. Combined treatments are however also responsible for cumulative side effects. The aim of reconstructive surgery with a flap is to restore a function lost with the loss of substance from the tumor resection. However, changes in reconstructive surgery have impact of postoperative radiotherapy planning. The optimization of imaging protocols for radiotherapy planning should m...
Source: Bulletin du Cancer - March 29, 2024 Category: Cancer & Oncology Authors: Alice Blache Florent Carsuzaa Arnaud Beddok Sophie Deneuve Pierre-Yves Marcy Dylan James Catherine Dejean St éphanie Dapké Bernard Devauchelle Juliette Thariat Source Type: research
Why do second-cycle medical students choose oncology? A literature overview
DISCUSSION: The literature on this topic is particularly scarce. No qualitative studies have been published in the English language. The limited data in the literature do not allow us to fully comprehend the problem.PMID:38553287 | DOI:10.1016/j.bulcan.2024.02.003 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 29, 2024 Category: Cancer & Oncology Authors: Estelle M N Laurent Christophe Ducrocq Pierre-Yves Cren Khaled Boutaa Dominique Crie Nicolas Penel Source Type: research
Relationship between cancer status and medical response by an emergency dispatch center: From a French SAMU database
CONCLUSION: An MICU or an ambulance was more often dispatched for cancer patients than for others. Considering that cancer is a very frequent comorbidity in Western countries, knowledge of the patient's cancer status should be sought and taken into consideration when a patient seeks emergency help.PMID:38553288 | DOI:10.1016/j.bulcan.2024.02.001 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 29, 2024 Category: Cancer & Oncology Authors: D éborah Truan Damien Viglino Guillaume Debaty Mathieu Laramas Van Ngo Thi Hong S ébastien Bailly Anne Claire Toffart Source Type: research
An update on total neoadjuvant treatment of adenocarcinoma of the rectum
Bull Cancer. 2024 Mar 28:S0007-4551(24)00084-5. doi: 10.1016/j.bulcan.2024.02.004. Online ahead of print.ABSTRACTA major advance has been made in the management of rectal cancer, with the emergence in 2021 of total neoadjuvant treatment. The main publications from the RAPIDO and PRODIGE-23 trials reported a significant improvement in progression-free survival and the pathological complete response rate. The aim of this review is to synthesize recent data on neoadjuvant treatment of rectal cancer, to explain the long-term results of the RAPIDO and PRODIGE-23 trials, and to put them into perspective, considering current adva...
Source: Bulletin du Cancer - March 29, 2024 Category: Cancer & Oncology Authors: Maroussia Medioni Baptiste Cervantes Florence Huguet Jean-Baptiste Bachet Yann Parc Thierry Andr é J érémie H Lefèvre Romain Cohen Source Type: research
Pembrolizumab in combination with first-line chemotherapy with gemcitabine-cisplatin for advanced biliary tract cancer
Bull Cancer. 2024 Mar 28:S0007-4551(24)00111-5. doi: 10.1016/j.bulcan.2024.02.008. Online ahead of print.NO ABSTRACTPMID:38553290 | DOI:10.1016/j.bulcan.2024.02.008 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 29, 2024 Category: Cancer & Oncology Authors: Constance d'Abrigeon Neuzillet Cindy Source Type: research
Development of an artificial intelligence system to improve cancer clinical trial eligibility screening
This study suggests that artificial intelligence could yield sizable improvements over standard practices in several aspects of the patient screening process, as well as in approaches to feasibility, site selection, and trial selection.PMID:38503584 | DOI:10.1016/j.bulcan.2024.01.010 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 19, 2024 Category: Cancer & Oncology Authors: Maud G édor Emmanuel Desandes M élanie Chesnel Jean-Louis Merlin Fr édéric Marchal Aur élien Lambert Arnaud Baudin Source Type: research
SFCE harmonization workshops: Neonatal acute myeloid leukemia
The objective of this work is to review this rare pathology by addressing the clinical, biological, therapeutic and ethical particularities of patients with true neonatal AML or transient leukemoid reactions occurring in a constitutional trisomy 21 (true TAM) or somatic background (IMD).PMID:38503585 | DOI:10.1016/j.bulcan.2023.12.010 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 19, 2024 Category: Cancer & Oncology Authors: St éphane Ducassou Wadih Abou Chahla Nicolas Duployez Carine Halfon-Domenech Beno ît Brethon Marilyne Poir ée Tiphaine Adam de Beaumais Laurent Lema ître Nicolas Sirvent Arnaud Petit Source Type: research
Development of an artificial intelligence system to improve cancer clinical trial eligibility screening
This study suggests that artificial intelligence could yield sizable improvements over standard practices in several aspects of the patient screening process, as well as in approaches to feasibility, site selection, and trial selection.PMID:38503584 | DOI:10.1016/j.bulcan.2024.01.010 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 19, 2024 Category: Cancer & Oncology Authors: Maud G édor Emmanuel Desandes M élanie Chesnel Jean-Louis Merlin Fr édéric Marchal Aur élien Lambert Arnaud Baudin Source Type: research
SFCE harmonization workshops: Neonatal acute myeloid leukemia
The objective of this work is to review this rare pathology by addressing the clinical, biological, therapeutic and ethical particularities of patients with true neonatal AML or transient leukemoid reactions occurring in a constitutional trisomy 21 (true TAM) or somatic background (IMD).PMID:38503585 | DOI:10.1016/j.bulcan.2023.12.010 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 19, 2024 Category: Cancer & Oncology Authors: St éphane Ducassou Wadih Abou Chahla Nicolas Duployez Carine Halfon-Domenech Beno ît Brethon Marilyne Poir ée Tiphaine Adam de Beaumais Laurent Lema ître Nicolas Sirvent Arnaud Petit Source Type: research
Development of an artificial intelligence system to improve cancer clinical trial eligibility screening
This study suggests that artificial intelligence could yield sizable improvements over standard practices in several aspects of the patient screening process, as well as in approaches to feasibility, site selection, and trial selection.PMID:38503584 | DOI:10.1016/j.bulcan.2024.01.010 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 19, 2024 Category: Cancer & Oncology Authors: Maud G édor Emmanuel Desandes M élanie Chesnel Jean-Louis Merlin Fr édéric Marchal Aur élien Lambert Arnaud Baudin Source Type: research
SFCE harmonization workshops: Neonatal acute myeloid leukemia
The objective of this work is to review this rare pathology by addressing the clinical, biological, therapeutic and ethical particularities of patients with true neonatal AML or transient leukemoid reactions occurring in a constitutional trisomy 21 (true TAM) or somatic background (IMD).PMID:38503585 | DOI:10.1016/j.bulcan.2023.12.010 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 19, 2024 Category: Cancer & Oncology Authors: St éphane Ducassou Wadih Abou Chahla Nicolas Duployez Carine Halfon-Domenech Beno ît Brethon Marilyne Poir ée Tiphaine Adam de Beaumais Laurent Lema ître Nicolas Sirvent Arnaud Petit Source Type: research
Development of an artificial intelligence system to improve cancer clinical trial eligibility screening
This study suggests that artificial intelligence could yield sizable improvements over standard practices in several aspects of the patient screening process, as well as in approaches to feasibility, site selection, and trial selection.PMID:38503584 | DOI:10.1016/j.bulcan.2024.01.010 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 19, 2024 Category: Cancer & Oncology Authors: Maud G édor Emmanuel Desandes M élanie Chesnel Jean-Louis Merlin Fr édéric Marchal Aur élien Lambert Arnaud Baudin Source Type: research
SFCE harmonization workshops: Neonatal acute myeloid leukemia
The objective of this work is to review this rare pathology by addressing the clinical, biological, therapeutic and ethical particularities of patients with true neonatal AML or transient leukemoid reactions occurring in a constitutional trisomy 21 (true TAM) or somatic background (IMD).PMID:38503585 | DOI:10.1016/j.bulcan.2023.12.010 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 19, 2024 Category: Cancer & Oncology Authors: St éphane Ducassou Wadih Abou Chahla Nicolas Duployez Carine Halfon-Domenech Beno ît Brethon Marilyne Poir ée Tiphaine Adam de Beaumais Laurent Lema ître Nicolas Sirvent Arnaud Petit Source Type: research
Development of an artificial intelligence system to improve cancer clinical trial eligibility screening
This study suggests that artificial intelligence could yield sizable improvements over standard practices in several aspects of the patient screening process, as well as in approaches to feasibility, site selection, and trial selection.PMID:38503584 | DOI:10.1016/j.bulcan.2024.01.010 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 19, 2024 Category: Cancer & Oncology Authors: Maud G édor Emmanuel Desandes M élanie Chesnel Jean-Louis Merlin Fr édéric Marchal Aur élien Lambert Arnaud Baudin Source Type: research
